The role of angiogenesis in obstructive sleep apnea (OSA)

A. Arya, M. Stack, K. O‘Sullivan, F. Shanahan, C. P. Bredin (Wilton, Cork, Ireland)

Source: Annual Congress 2005 - Pathogenesis of OSA
Session: Pathogenesis of OSA
Session type: Thematic Poster Session
Number: 2319
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Arya, M. Stack, K. O‘Sullivan, F. Shanahan, C. P. Bredin (Wilton, Cork, Ireland). The role of angiogenesis in obstructive sleep apnea (OSA). Eur Respir J 2005; 26: Suppl. 49, 2319

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002

Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

The role of hyaluronan metabolism in obstructive sleep apnoea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Hyperuricaemia in females with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2003; 22: Suppl. 45, 91s
Year: 2003

The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005


Obesity, obstructive sleep apnea (OSA) and asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


NT-proBNP in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006

Bronchial inflammation in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 466s
Year: 2003

Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Has acoustic pharyngometry a role in screening for obstructive sleep apnea (OSA)?
Source: Eur Respir J 2005; 26: Suppl. 49, 259s
Year: 2005

Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Hyperuricaemia in males with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Effect of smoking on obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Screening for obstructive sleep apnea (OSA) in acromegaly
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020


The role of Mallampati score in obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2007 - Clinical aspects of obstructive sleep apnoea
Year: 2007


The role of inflammatory biomarkers in obstructive sleep apnea syndrome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018

Neurophysiological properties of the tongue in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 495s
Year: 2002